Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
European Urology
|
September 20, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancer
Neil E Martin, Laura Massey, Caleb Stowell, et al.
European Urology
|
July 7, 2020
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]
David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
European Urology
|
October 11, 2016
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
Thomas J Johnston, Greg L Shaw, Alastair D Lamb, et al.
European Urology
|
November 28, 2019
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
Health Technology Assessment (Winchester, England)
|
August 11, 2020
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
World Journal of Urology
|
November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases
Paolo Gontero, Francesca Pisano, Joan Palou, et al.
Nature Reviews. Urology
|
April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus
Roberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
European Urology
|
September 20, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancer
Neil E Martin, Laura Massey, Caleb Stowell, et al.
European Urology
|
July 7, 2020
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]
David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
European Urology
|
October 11, 2016
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
Thomas J Johnston, Greg L Shaw, Alastair D Lamb, et al.
European Urology
|
November 28, 2019
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
Health Technology Assessment (Winchester, England)
|
August 11, 2020
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
World Journal of Urology
|
November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases
Paolo Gontero, Francesca Pisano, Joan Palou, et al.
Nature Reviews. Urology
|
April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus
Roberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Page
of 6